Craft
AltruBio

AltruBio

Total Funding

$39.7 M

AltruBio Summary

Company summary

Overview
AltruBio (formerly AbGenomics) is a biopharmaceutical company focused on developing antibody therapeutics for the treatment of cancer and immune-related inflammatory diseases. It builds a discovery platform to identify and validate antibody therapeutics. The company develops an immune checkpoint agonist antibody, a gastrointestinal (GI) tumor-selective antigen, and a linker for antibody-drug conjugate products. Its drug candidates designed for treating T Cell mediated diseases and GI oncological diseases.
Type
Private
Founded
2006
HQ
Redwood City, CA, US | view all locations
Website
https://www.altrubio.com/
Cybersecurity rating
Sectors

Key people

  • Judy Chou

    Judy Chou, President and Chief Executive Officer

    • Patrick Y. Yang

      Patrick Y. Yang, Chairman of the Board

      • Shih-Yao Lin

        Shih-Yao Lin, President of AltruBio Taiwan and Head of Clinical Development

        LocationsView all

        3 locations detected

        • Redwood City, CA HQ

          United States

          555 Twin Dolphin Dr #310

        • Amsterdam, NH

          Netherlands

          Kingsfordweg 103

        • Taipei City

          Taiwan

          Neihu District

        Footer menu